Clinical Trials
24
Active:17
Completed:1
Trial Phases
2 Phases
Phase 1:21
Phase 2:1
Drug Approvals
1
EMC:1
Drug Approvals
KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusion
- Approval Date
- Jul 7, 2025
EMC
Clinical Trials
Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials
Phase 1
21 (87.5%)phase_1_2
1 (4.2%)Phase 2
1 (4.2%)phase_2_3
1 (4.2%)No trials found
News
No news found